Product Information
DUTASTERIDE-TAMSULOSIN 0.5-0.4 is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.9736 per EA under NDC 68382064016. Its NADAC has been published 421 times since Sep 12, 2018.
FDA first approved this application on May 24, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; .4 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382064016
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207769FDA Approved
5/24/2018
TE Code
AB
On Market Since
6/4/2018
Pharmacological Classes
Price Statistics
The NADAC for DUTASTERIDE-TAMSULOSIN 0.5-0.4 has been published 421 times since Sep 12, 2018, and over the history we have for it it has declined 29.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9736 per EA |
|---|---|
| All-time high | $2.8428 (Nov 11, 2020) |
| All-time low | $1.6489 (May 22, 2024) |
| 52-week high | $2.4047 |
| 52-week low | $1.9528 |
| Median price | $2.2781 |
| Average price | $2.2661 |
| Largest weekly change | +27.5% (Sep 18, 2024) |
| Weeks tracked | 421 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dutasteride and tamsulosin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
5-alpha Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DUTASTERIDE-TAMSULOSIN 0.5-0.4?
The current National Average Drug Acquisition Cost (NADAC) for DUTASTERIDE-TAMSULOSIN 0.5-0.4, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.9736 per EA (NDC 68382064016), effective Sep 30, 2026.
How has the price of DUTASTERIDE-TAMSULOSIN 0.5-0.4 changed over time?
Over the history we have for it, the NADAC for DUTASTERIDE-TAMSULOSIN 0.5-0.4 has declined 29.4%. It has been tracked across 421 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for DUTASTERIDE-TAMSULOSIN 0.5-0.4?
Since Sep 12, 2018, the NADAC for DUTASTERIDE-TAMSULOSIN 0.5-0.4 has ranged from a low of $1.6489 (May 22, 2024) to a high of $2.8428 (Nov 11, 2020), with a median of $2.2781 per EA.
Are there cheaper alternatives to DUTASTERIDE-TAMSULOSIN 0.5-0.4?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DUTASTERIDE-TAMSULOSIN 0.5-0.4 in a comparable dosage form, but none are currently priced below it.
Who manufactures DUTASTERIDE-TAMSULOSIN 0.5-0.4?
DUTASTERIDE-TAMSULOSIN 0.5-0.4 (NDC 68382064016) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.